Cryo-Cell International Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 57/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 8.50.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cryo-Cell International Inc's Score
Industry at a Glance
Industry Ranking
57 / 78
Overall Ranking
285 / 4582
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Hold
Current Rating
8.500
Target Price
+86.81%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cryo-Cell International Inc Highlights
StrengthsRisks
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Growing
The company is in a growing phase, with the latest annual income totaling USD 31.99M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Undervalued
The company’s latest PE is -65.71, at a low 3-year percentile range.
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Ticker SymbolCCEL
CompanyCryo-Cell International Inc
CEOPortnoy (Mark L)
Websitehttps://www.cryo-cell.com/
FAQs
What is the current price of Cryo-Cell International Inc (CCEL)?
The current price of Cryo-Cell International Inc (CCEL) is 3.750.
What is the symbol of Cryo-Cell International Inc?
The ticker symbol of Cryo-Cell International Inc is CCEL.
What is the 52-week high of Cryo-Cell International Inc?
The 52-week high of Cryo-Cell International Inc is 8.790.
What is the 52-week low of Cryo-Cell International Inc?
The 52-week low of Cryo-Cell International Inc is 3.570.
What is the market capitalization of Cryo-Cell International Inc?
The market capitalization of Cryo-Cell International Inc is 30.21M.
What is the net income of Cryo-Cell International Inc?
The net income of Cryo-Cell International Inc is 402.10K.
Is Cryo-Cell International Inc (CCEL) currently rated as Buy, Hold, or Sell?
According to analysts, Cryo-Cell International Inc (CCEL) has an overall rating of Hold, with a price target of 8.500.
What is the Earnings Per Share (EPS TTM) of Cryo-Cell International Inc (CCEL)?
The Earnings Per Share (EPS TTM) of Cryo-Cell International Inc (CCEL) is -0.056.